3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
65
Other hematologic neoplasm
5
Classical hematology
5
Breast
5
Gynecologic
4
Gastrointestinal
4
Other
3
Genitourinary
3
Lymphoid
2
Head & Neck
2
Thoracic
1
Sarcoma
1
Plasma cell
1
NET
1
Myeloid
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Neuroendocrine Tumors
3
Stomach Neoplasms
1
Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
Everolimus
5
Sunitinib
4
lutetium Lu 177 dotatate
2
PM 01183
2
Octreotide
2
Doxorubicin
2
trifluridine tipiracil drug combination
1
telotristat ethyl
1
repotrectinib
1
pralsetinib
1
pegfilgrastim
1
pasireotide
1
motesanib diphosphate
1
epothilone B
1
dactolisib
1
copper dotatate CU-64
1
batifiban
1
avelumab
1
alectinib
1
Temozolomide
1
TKM-080301
1
Surveys and Questionnaires
1
SNX-5422
1
Referral and Consultation
1
Radiomics
1
Quality of Life
1
Patient Reported Outcome Measures
1
Oxaliplatin
1
Molecular Diagnostic Techniques
1
Lutetium-177
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Surveys and Questionnaires
×
NET
×
Clear all
NCT07258810
2025-12-02
ETP-NET
Hospices Civils de Lyon
Not yet recruiting
100 enrolled